Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease

The mineralocorticoid hormone aldosterone regulates sodium and potassium homeostasis but also adversely modulates the maladaptive process of cardiac adverse remodeling post-myocardial infarction. Through activation of its mineralocorticoid receptor (MR), a classic steroid hormone receptor/transcript...

Full description

Bibliographic Details
Main Authors:	Barbara M. Parker, Shelby L. Wertz, Celina M. Pollard, Victoria L. Desimine, Jennifer Maning, Katie A. McCrink, Anastasios Lymperopoulos
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	International Journal of Molecular Sciences
Subjects:	adverse remodeling aldosterone cardiac myocyte crosstalk G protein-coupled receptor (GPCR) GPCR-kinase (GRK) heart failure inflammation mineralocorticoid receptor myocardial infarction oxidative stress signal transduction
Online Access:	https://www.mdpi.com/1422-0067/19/12/3764

Similar Items

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
by: Jennifer Maning, et al.
Published: (2020-04-01)

Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function
by: Mariona Guitart-Mampel, et al.
Published: (2021-06-01)

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis.
by: Mary Elizabeth Moss, et al.
Published: (2015-09-01)

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
by: Alessandro Cannavo, et al.
Published: (2019-08-01)

GRKs as Key Modulators of Opioid Receptor Function
by: Laura Lemel, et al.
Published: (2020-11-01)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
by: Luo Shi, et al.
Published: (2019-11-01)

Historical Perspective of the G Protein-Coupled Receptor Kinase Family
by: Jeffrey L. Benovic
Published: (2021-03-01)

GRKs as Modulators of Neurotransmitter Receptors
by: Eugenia V. Gurevich, et al.
Published: (2021-12-01)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
by: Greg H. Tesch, et al.
Published: (2017-05-01)

βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?
by: Anastasios Lymperopoulos, et al.
Published: (2013-12-01)

Deletion of Osteopontin Enhances β<sub>2</sub>-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes
by: Celina M. Pollard, et al.
Published: (2019-03-01)

Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015
by: Yu F Osmolovskaya, et al.
Published: (2015-09-01)

The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
by: Rene Baudrand, et al.
Published: (2018-02-01)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01)

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
by: Yugar-Toledo JC, et al.
Published: (2017-10-01)

Les cibles moléculaires du récepteur minéralocorticoïde dans le coeur
by: Gravez, Basile
Published: (2015)

Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
by: S N Tereshchenko, et al.
Published: (2013-12-01)

Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
by: Jin Young Lee, et al.
Published: (2021-08-01)

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
by: Marie Pieronne‐Deperrois, et al.
Published: (2021-06-01)

Regulation Role of Non-Rhodopsin G Protein-coupled Receptor Kinases on Tumor
by: LI Ruirui, et al.
Published: (2019-04-01)

GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo
by: Celina M. Pollard, et al.
Published: (2020-01-01)

Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization
by: Preeti Kumari Chaudhary, et al.
Published: (2020-05-01)

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
by: Stefania Gorini, et al.
Published: (2018-09-01)

G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases
by: Cristina Murga, et al.
Published: (2019-02-01)

Aldosterone nongenomically induces angiotensin II receptor dimerization in rat kidney: role of mineralocorticoid receptor and NADPH oxidase
by: Kittisak Sinphitukkul, et al.
Published: (2019-08-01)

Targeting GRK5 for Treating Chronic Degenerative Diseases
by: Federica Marzano, et al.
Published: (2021-02-01)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
by: Vsevolod V. Gurevich, et al.
Published: (2019-02-01)

A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D<sub>2</sub>-like Receptors
by: Lisa Forster, et al.
Published: (2020-08-01)

Mineralocorticoid Receptor Antagonists
by: Ilaria Spoletini, et al.
Published: (2019-01-01)

The tubulogenic effect of aldosterone is attributed to intact binding and intracellular response of the mineralocorticoid receptor
by: Minuth Will, et al.
Published: (2007-09-01)

Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
by: A. M. Esayan, et al.
Published: (2018-04-01)

Cardiac Mineralocorticoid Receptor and the Na+/H+ Exchanger: Spilling the Beans
by: Irene Lucía Ennis, et al.
Published: (2021-01-01)

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
by: Stephen eOrena, et al.
Published: (2013-10-01)

A<sub>2A</sub> Receptor Homodimer-Disrupting Sequence Efficiently Delivered by a Protease-Resistant, Cyclic CPP Vector
by: Maria Gallo, et al.
Published: (2019-10-01)

Evolutionary analysis of functional divergence among chemokine receptors, decoy receptors and viral receptors
by: Hiromi eDaiyasu, et al.
Published: (2012-07-01)

The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
by: Michel F. Rossier, et al.
Published: (2021-06-01)

Análise comparativa de perfis de sinalização do receptor AT1 ativado por agonistas seletivos para a via de -arrestinas
by: Santos, Geisa Aparecida dos
Published: (2013)

Análise comparativa de perfis de sinalização do receptor AT1 ativado por agonistas seletivos para a via de -arrestinas
by: Geisa Aparecida dos Santos
Published: (2013)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
by: Ivana Bjelobaba, et al.
Published: (2018-04-01)

Receptor–Receptor Interactions and Glial Cell Functions with a Special Focus on G Protein-Coupled Receptors
by: Diego Guidolin, et al.
Published: (2021-08-01)